Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohortJ Mazières, F Barlesi, T Filleron, et al.
The British Journal of Radiology|September 27, 2014
Future development of biologically relevant dosimetryH Palmans, H Rabus, A L Belchior, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2018
Long-term survival in patients with advanced non-small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK studyJ von Pawel, R Bordoni, M Satouchi, et al.
ESMO Open|December 25, 2021
IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancerO Molinier, B Besse, F Barlesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) programC Leduc, J P Merlio, B Besse, et al.
Respiratory Medicine and Research|May 17, 2020
Somatic profile in lung cancers is associated to reproductive factors in never-smokers women: Results from the IFCT-1002 BioCAST studyC Fontaine-Delaruelle, J Mazières, J Cadranel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trialB Besse, J Mazières, L Ribassin-Majed, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 29, 2019
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancerN Tarazona, F Gimeno-Valiente, V Gambardella, et al.
ESMO Open|March 1, 2022
Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU studyN Girard, S Galland-Girodet, V Avrillon, et al.
ESMO Open|November 11, 2023
Sequencing paired tumor DNA and white blood cells improves circulating tumor DNA tracking and detects pathogenic germline variants in localized colon cancerF Gimeno-Valiente, J Martín-Arana, R Tébar-Martínez, et al.
Pageof 19